Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
theranos
4
×
startups
bio
tc
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
axial spondyloarthritis
bausch health
bio-repository
biogen
biotech
boston blog main
boston top stories
boston university
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
cancer immunotherapy
car-t immunotherapy
cell therapy
centers for medicare and medicaid services
clinical trials
cluster headache
column
crispr
deals
detroit blog main
detroit top stories
developmental biology
diagnostics
digital health
dihydroergotamine
dimitry nuyten
What
bio
4
×
blood
read
company
medical
startup
tech
theranos
troubled
according
akin
analysis
approval
beleaguered
big
biggest
biogen’s
biopharmaceutical
centers
ceo
chief
claims
cms
companies
convo
coo
create
crowdsourced
currently
devices
diagnostics
disruptive
diverse
doctors
drug
earlier
edison
fact
failures
federal
Language
Current search:
theranos
×
bio
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@techcrunch.com
7 years ago
Regenerative medicine today is like the internet in 1993
@techcrunch.com
7 years ago
Theranos reportedly voids two years of reports from its Edison blood-testing devices
@techcrunch.com
7 years ago
Theranos’ COO retires as the troubled bio-tech startup overhauls its organizational structure
